Clinical Trials Browser

Phase 2 × Anal Canal Carcinoma × toripalimab × Clear all

NCT05060471 2024-12-03

PD-1 Blockade Combined with Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients

Phase 2 Completed

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms